poor inhibitory activity against vancomycin resistant e faecalis (ATCC)
99
Structured Review
ATCC
poor inhibitory activity against vancomycin resistant e faecalis
Poor Inhibitory Activity Against Vancomycin Resistant E Faecalis, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 741 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/poor+inhibitory+activity+against+vancomycin+resistant+e+faecalis/Enterococcus+faecalis/pm31894862-78-3-10
Average 99 stars, based on 741 article reviews
Poor Inhibitory Activity Against Vancomycin Resistant E Faecalis, supplied by ATCC, used in various techniques. Bioz Stars score: 99/100, based on 741 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/poor+inhibitory+activity+against+vancomycin+resistant+e+faecalis/Enterococcus+faecalis/pm31894862-78-3-10
Average 99 stars, based on 741 article reviews
poor inhibitory activity against vancomycin resistant e faecalis - by Bioz Stars,
2026-09
99/100 stars
Images
Related Articles
Activity Assay:Article Title: Exploration of (3-benzyl-5-hydroxyphenyl)carbamates as new antibacterial agents against Gram-positive bacteria. Article Snippet: Funding information National Natural Science Foundation of China, Grant/Award Number: 21772240; Guangzhou Science Technology and Innovation Commission, Grant/Award Number: 201707010210 Abstract A series of (3‐benzyl‐5‐hydroxyphenyl)carbamates were evaluated as new antibacterial agents.. Several compounds showed potent inhibitory activity against sensitive and drug‐resistant Gram‐positive bacteria.. The compounds are ineffective against all tested Gram‐negative bacteria. |